Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FP187 dimethyl fumarate in moderate to severe plaque psoriasis
2010-020168-39Phase 2Completed
- Sponsor
- Forward Pharma
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dimethyl fumarate in psoriasis and plaque psoriasis (4 arms), sponsored by Forward Pharma. Primary endpoint: PASI 75 response at week 20. Started Jun 2010; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on 2010-020168-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020168-39.